Literature DB >> 33307166

One-carbon epigenetics and redox biology of neurodegeneration.

Fabio Coppedè1.   

Abstract

One-carbon metabolism provides the methyl groups for both DNA and histone tail methylation reactions, two of the main epigenetic processes that tightly regulate the chromatin structure and gene expression levels. Several enzymes involved in one-carbon metabolism, as well as several epigenetic enzymes, are regulated by intracellular metabolites and redox cofactors, but their expression levels are in turn regulated by epigenetic modifications, in such a way that metabolism and gene expression reciprocally regulate each other to maintain homeostasis and regulate cell growth, survival, differentiation and response to environmental stimuli. Increasing evidence highlights the contribution of impaired one-carbon metabolism and epigenetic modifications in neurodegeneration. This article provides an overview of DNA and histone tail methylation changes in major neurodegenerative disorders, namely Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, discussing the contribution of oxidative stress and impaired one-carbon and redox metabolism to their onset and progression.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyotrophic lateral sclerosis; Epigenetics; Methylation; Neurodegeneration; One-carbon metabolism; Parkinson's disease; Redox biology

Mesh:

Substances:

Year:  2020        PMID: 33307166     DOI: 10.1016/j.freeradbiomed.2020.12.002

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Nat Rev Neurol       Date:  2022-09-30       Impact factor: 44.711

Review 2.  Mitochondrial DNA Methylation and Human Diseases.

Authors:  Andrea Stoccoro; Fabio Coppedè
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

3.  Aberrant redox biology and epigenetic reprogramming: Co-conspirators across multiple human diseases.

Authors:  Frederick E Domann; Michael J Hitchler
Journal:  Free Radic Biol Med       Date:  2021-04-29       Impact factor: 8.101

4.  Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective.

Authors:  Fabio Coppede
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

Review 5.  Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.

Authors:  Alma Rosa Lezama Toledo; Germán Rivera Monroy; Felipe Esparza Salazar; Jea-Young Lee; Shalini Jain; Hariom Yadav; Cesario Venturina Borlongan
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 6.  Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

Authors:  Ariel Frajerman; Linda Scoriels; Oussama Kebir; Boris Chaumette
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

7.  Untargeted Plasma Metabolomics Unravels a Metabolic Signature for Tissue Sensitivity to Glucocorticoids in Healthy Subjects: Its Implications in Dietary Planning for a Healthy Lifestyle.

Authors:  Nicolas C Nicolaides; Maria-Konstantina Ioannidi; Eleni Koniari; Ifigeneia Papageorgiou; Anastasia Bartzeliotou; Amalia Sertedaki; Maria I Klapa; Evangelia Charmandari
Journal:  Nutrients       Date:  2021-06-21       Impact factor: 5.717

Review 8.  One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration.

Authors:  Eirini Lionaki; Christina Ploumi; Nektarios Tavernarakis
Journal:  Cells       Date:  2022-01-09       Impact factor: 6.600

Review 9.  Impaired Folate-Mediated One-Carbon Metabolism in Type 2 Diabetes, Late-Onset Alzheimer's Disease and Long COVID.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.